ANP Anpario plc
Anpario plc, together with its subsidiaries, manufactures and distributes animal feed additives for animal health, nutrition, and biosecurity in the Americas, Asia, Europe, the Middle East, and Africa. The company offers animal gut health products, such as phytogenic and acid based eubiotics, and omega fatty acids under the AmpLIPhy, Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; and feed products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands. It also provides water sanitation tablets, an insect control powders and natural drying agents under the Red Lite, Credence, Mitex, and Clean & Dry brands; and toxin management category products consisting of mycotoxin binders under the Anpro brand. The company was formerly known as Kiotech International plc and changed its name to Anpario plc in November 2011. Anpario plc was founded in 1996 and is headquartered in Worksop, the United Kingdom.…
Industry Peers
Packaged FoodsKey Statistics
About Anpario (LON: ANP)
›
Anpario (LON: ANP) is listed on the London Stock Exchange, where its shares trade in pence sterling (GBp). It belongs to the Packaged Foods industry, part of the Consumer Defensive sector, and reports about 162 employees.
The shares were at 520.00 GBp on 19 November 2026, up 4.0% over 52 weeks.
At a market capitalisation of 84.47M GBP, it trades at 13.3 times trailing earnings and 12.0 times forward earnings. The median trailing P/E of its 18 largest Packaged Foods peers is 24.8, a discount of 46% for ANP. It pays a dividend yielding 2.48% (it pays out 29% of its earnings), against a median of 3.60% among the dividend payers in that peer group.
Anpario reports return on equity of 16.5%, an operating margin of 16.9% and revenue up 6.9% year over year.
It holds more cash than debt, a net cash position of 10.70M GBP. Its Piotroski F-score is 7 out of 9, a strong reading of its financial health. 2 analysts cover the stock; their mean price target of 613.00 GBp is 17.9% above the current price.